mobile
mobile mobile

Website Analysis

img Sarepta.com

Last Analyzed : 01.08.2020
Sarepta.com recives any estimated n/a unique visitors and n/a unique page views per day. Revenue gained from these much visits may be n/a per day from various advertising sources. The estimated worth of site is n/a.
  • Website Age n/a
  • Alexa Rank no-data
  • Country imgUnited States
  • IP Address 54.204.43.126
META INFORMATION icon
Title
Sarepta Ther***utics | Biopharmaceutical Company for Rare Diseases
Description
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Keywords
-
Content Type
utf-8
No Meta Name Value
1 viewport width=device-width, initial-scale=1.0
2 viewport width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no
GENERAL HTML INFORMATION icon
Type Status
HTML 5 img
Responsive Website img
HTML SIZE INFORMATION icon
Text / Code Ratio 6.89 %
sarepta.com has a website text/code ratio of 6.89 %. Search engine crawlers tend to not pick up pages with inadequate content.
IMPORTANT HTML TAGS AND COUNTS icon
Titles icon
  • H10
  • H219
  • H30
  • H44
  • H54
  • H60
H2
No Text
1 Press releases (2)
2 Utility menu (2)
3 Regional navigation (2)
4 Main navigation (2)
5 Social links
6 We see a revolution.
7 Our scientists would disagree.
8 So neither will we.
9 Join us.
10 Sarepta’s response to covıd-19
SEE MORE
H4
No Text
1 Exploring the potential of gene therapies for limb-girdle muscular dystrophies
2 Rna-targeted therapies: a development strategy for protein upregulation
3 A new fda-approved treatment
4 Sarepta ther***utics' presentation from the 38th annual j.p. morgan healthcare conference (2020)
H5
No Text
1 Some see slow and steady scientific progress.
2 Some think a cure for a rare disease is a miracle.
3 Patients can’t wait for the next breakthrough in medical research.
4 The opportunity to transform lives is breathtaking.
Text Styling icon
  • STRONG9
  • B0
  • EM0
  • I0
  • U0
  • CITE0
STRONG
No Text
1 Sarepta Ther***utics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (2)
2 Sarepta Ther***utics to Announce Second Quarter 2020 Financial Results and Recent Corporate Developments on August 5, 2020 (2)
3 Sarepta Ther***utics Receives Fast Track Designation for SRP-9001 Micro-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy (2)
4 For patients in the U.S. taking an approved Sarepta therapy,
5 For partic****nts in Sarepta-sponsored clinical trials,
6 Resources for patients and caregivers
WEBSITE SERVER INFORMATION icon
  • Service Provider (ISP)
  • Amazon.com, Inc.
  • Hosted IP Address
  • 54.204.43.126
  • Hosted Country
  • imgUnited States
  • Host Region
  • Virginia , Ashburn
  • Latitude and Longitude
  • 39.0438 : -77.4874
COUNTRIES More
Last Updated Websites
Last viewed websites
LASTEST ANALYZED WEBSITES
HOW DO I REMOVE MY WEBSITE ?
REPORT THIS WEBSITE

SHARE THIS ANALYSIS